Founded in 2015 from tissue-engineering work at Weill Cornell Medicine, Fesarius Therapeutics develops regenerative medical devices for wound care and reconstructive surgery. Its flagship product, DermiSphere hDRT, is an FDA-cleared hydrogel dermal regeneration template designed to support treatment of full-thickness skin loss. The company was co-founded by plastic surgeon and Weill Cornell professor Dr. Jason Spector, whose clinical experience shaped the technology.
FDA 510(k) marketing authorization
Registration
NeuEsse IncNeuEsse Inc. develops plant-based skin-repair technology, led by its soy-protein OmegaSkin™ human skin substitute for wounds, burns and other injuries. Based in Dunbar, Pennsylvania, the company also is developing a liquid skin formulation and a handheld electrospinner intended to deliver treatments without refrigeration, special handling or direct-touch application. Founder and CEO Joe Connell brings more than 38 years of pharmaceutical and biotechnology experience to the venture.339113DUNBAR, PA
Exsurco MedicalFrom its stand-alone medical-device manufacturing facility, Exsurco Medical engineers and makes precision devices for skin grafting, wound debridement, and tissue-bank recovery. The Wakeman company’s Amalgatome platform grew from tissue-bank tools into the Amalgatome SD, a surgical device for burn and trauma care, while its products have expanded into international tissue-bank markets. Exsurco opened its manufacturing facility and received ISO 13485 certification in 2015.WAKEMAN, OH
NoxsanoFounded by scientists and healthcare professionals with experience at Procter & Gamble and McKesson, Noxsano is a wound-care company developing treatments for veterinary and human medicine. Its patented technology delivers nitric oxide at the wound site, with veterinary use serving as the company’s initial market before planned expansion into human care.CINCINNATI, OH